Yamauchi Ryo, Takata Kazuhide, Shinagawa Yoshinobu, Tanaka Takashi, Fukuda Hiromi, Fukuda Sho, Kunimoto Hideo, Umeda Kaoru, Morihara Daisuke, Yokoyama Keiji, Takeyama Yasuaki, Irie Makoto, Shakado Satoshi, Mizoguchi Mikirou, Hisano Satoshi, Yoshimitsu Kengo, Sakisaka Shotaro
Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan.
Department of Radiology, Fukuoka University Faculty of Medicine, Japan.
Intern Med. 2019 Mar 1;58(5):661-665. doi: 10.2169/internalmedicine.0973-18. Epub 2018 Nov 19.
A 70-year-old man was admitted for treatment of a single liver nodule that was detected by contrast-enhanced computed tomography. Twenty years earlier, the patient had been diagnosed with myelodysplastic syndrome-refractory anemia and secondary hemochromatosis but had not received erythrocyte transfusions. The current histological, computed tomography, and magnetic resonance imaging findings revealed hepatocellular carcinoma (HCC) and non-cirrhotic liver hemochromatosis. The liver tumor was treated using radiofrequency ablation therapy. Secondary hemochromatosis may be a risk factor for HCC, even if the liver is not cirrhotic. In such cases, additional surveillance may be required to detect the development of HCC.
一名70岁男性因对比增强计算机断层扫描发现的单个肝脏结节入院治疗。20年前,该患者被诊断为骨髓增生异常综合征-难治性贫血和继发性血色素沉着症,但未接受红细胞输血。目前的组织学、计算机断层扫描和磁共振成像结果显示为肝细胞癌(HCC)和非肝硬化性肝脏血色素沉着症。肝脏肿瘤采用射频消融治疗。即使肝脏没有肝硬化,继发性血色素沉着症也可能是HCC的危险因素。在这种情况下,可能需要额外的监测来检测HCC的发生。